第94回日本細菌学会総会

講演情報

ワークショップ

[WS8] 低酸素環境と疾患(がん、感染症)の分子論

2021年3月25日(木) 12:45 〜 14:45 チャンネル2

コンビーナー:鈴木 敏彦(東京医科歯科大学)

[WS8-1] 低酸素下でがん性代謝が確立される分子機構

○中山 恒 (旭川医大・医・薬理学)

When our body is exposed to hypoxic condition, we regulate metabolism, respiration, and erythropoiesis to adapt to the condition. Hypoxia-Inducible Factor (HIF) plays a central role in this process. Pyruvate dehydrogenase (PDH) is an enzyme which catalyzes the production of acetyl CoA from pyruvate. PDH consists of five subunits; E1α, E1β, E2, E3 and E3BP. Under hypoxic condition, HIF induces PDH kinase and promotes the phosphorylation of PDH-E1α to inhibit its activity. This pathway leads to the energetic conversion in hypoxia: from oxidative phosphorylation to glycolysis. In addition, we identified a new machinery to switch the metabolic status under prolonged hypoxic condition.
When breast cancer cell line was cultured in prolonged hypoxia, PDH-E1β is downregulated and the PDH activity is repressed. Further, downregulation of PDH-E1β was sustained after reoxygenation, which contributed to the aerobic glycolysis in cancer cells. Furthermore, knockdown (KD) of PDH-E1β created the aerobic glycolysis status, indicating that reduction of PDH activity plays a critical role on metabolic switching. Importantly, KD of PDH in cancer cells inhibited its growth even though they exhibit typical cancer metabolism. I would like to discuss a possible connection between the tumor metabolism and malignant phenotype of cancer cells, hoping to extend this notion to the study of microbiology.